Medical News

RSS

More than 10 million people in the UK receive COVID-19 booster jabs

More than 10 million people have now received their COVID-19 booster or third jabs, the latest figures show, ensuring the vital protection they have secured from their first two doses is maintained over the winter months.

8 Nov 2021

Researchers explain why decaying SARS-CoV-2 antibodies in blood are not a problem after vaccination

A new study published in the preprint bioRxiv* server suggests vaccination helps to inflate the number of somatic hypermutations acquired by B cells. The increase in somatic hypermutations allows for an accumulation of highly matured bone marrow plasma cells.

8 Nov 2021

Pacific oyster shows antiviral activity against human coronavirus HCoV-229E

Not only are Pacific oysters (Crassostrea gigas) a seafood delicacy, but they may also be key for helping scientists figure out how to stop the spread of coronaviruses.

7 Nov 2021

Rapid antibody response induced by mRNA COVID vaccines in mice

A new study posted in the bioRxiv* preprint server used mouse models to investigate how mRNA vaccines elicit a rapid antibody response. Their findings show two different mRNA vaccines successfully boost antibody levels — IL-5, IL-6, and MCP-1 —5 days after administration.

7 Nov 2021

Highly-sensitive PCR-based method to detect SARS-CoV-2 variants

A team of UK-based scientists has recently developed an allele-specific probe polymerase chain reaction method that can accurately detect different variants/lineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory samples. Furthermore, the method can detect viral variants even in samples with low viral RNA or degraded viral RNA. The study is currently available on the medRxiv* preprint server.

7 Nov 2021

Pacific oyster as a weapon against SARS-CoV-2

According to an article published in the journal Reviews in Medical Virology, the effectiveness of mollusc-derived antiviral agents has been proven in many different laboratory and animal studies, while its efficacy against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also been proposed by recent in silico studies.

7 Nov 2021

New data points to major SARS-CoV-2 animal reservoir in deer in Iowa

A new study tests the hypothesis that white-tailed deer are susceptible to SARS-CoV-2 infection.

7 Nov 2021

Reducing airborne transmission of infectious respiratory viruses with portable air purifiers

A new computational study focuses on the performance of portable air purifiers based on Computational Fluid Dynamics (CFD) simulations.

7 Nov 2021

The importance of exercise for those with diabetes in the COVID era

A review aims to evaluate the effectiveness of physical activity in people with type 2 diabetes and COVID-19.

7 Nov 2021

Fast evolution of SARS-CoV-2 driven by extensive RNA deamination by host cells

A new study proposed that the RNA structure and the genome component may serve as an important basis of different deamination spectrums in SARS-CoV-2.

7 Nov 2021

Dramatic reduction in cervical cancer in the UK following the introduction of HPV vaccination

The current study assessed the impact of HPV vaccination on the rates of cervical cancer and cervical carcinoma in situ.

7 Nov 2021

New CDC report discusses efficacy of mRNA COVID vaccines in immunocompromised

The U.S. CDC reports the observed efficacy among the immunocompromised population following vaccination with mRNA vaccines against SARS-CoV-2.

7 Nov 2021

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

A new study describes a new small molecule compound that has shown impressive safety, tolerability, and bioavailability against SARS-CoV-2.

7 Nov 2021

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

A recent study assesses the boost in antibodies against SARS-CoV-2)variants post-vaccination in plasma samples from previously infected COVID-19 patients.

7 Nov 2021

Experts reveal improved survival for patients with two out of three types of advanced breast cancer

Patients with two out of the three most common types of advanced breast cancer now have an average survival time of at least five years, according to a panel of experts at the Advanced Breast Cancer Sixth International Consensus Conference (ABC 6).

7 Nov 2021

Study examines benefits of SGLT2 inhibitors in individuals with type 1 diabetes

In addition to lowering blood sugar levels, diabetes drugs called sodium-glucose cotransporter 2 (SGLT2) inhibitors can provide kidney- and cardiovascular-related benefits for people with type 2 diabetes.

7 Nov 2021

SARS-CoV-2 infection amplifies immune system–related differences in dialysis, kidney transplant patients

People with kidney failure who are on dialysis or who have received a kidney transplant face a higher risk of dying from COVID-19.

7 Nov 2021

Risk factors for "long-haul" COVID in people with rheumatic diseases identified

A new study by researchers at Hospital for Special Surgery (HSS) in New York City demonstrates over half of patients with rheumatic diseases who contracted COVID-19 during the pandemic and completed a COVID-19 survey, experienced so-called "long-haul" COVID, or prolonged symptoms of the infection, including loss of taste or smell, muscle aches and difficulty concentrating, for one month or longer.

7 Nov 2021

Global effort focuses on developing better methods to quantify joint damage in rheumatoid arthritis patients

Crowdsourcing has become an increasingly popular way to develop machine learning algorithms to address many clinical problems in a variety of illnesses.

7 Nov 2021

Health and Social Care Secretary urges people in the UK to get COVID-19 booster jabs

Health and Social Care Secretary Sajid Javid has called for the UK to come together to help vaccinate those most vulnerable to COVID-19 with booster jabs.

7 Nov 2021

Medical News

More than 10 million people in the UK receive COVID-19 booster jabs

Researchers explain why decaying SARS-CoV-2 antibodies in blood are not a problem after vaccination

Pacific oyster shows antiviral activity against human coronavirus HCoV-229E

Rapid antibody response induced by mRNA COVID vaccines in mice

Highly-sensitive PCR-based method to detect SARS-CoV-2 variants

Pacific oyster as a weapon against SARS-CoV-2

New data points to major SARS-CoV-2 animal reservoir in deer in Iowa

Reducing airborne transmission of infectious respiratory viruses with portable air purifiers

The importance of exercise for those with diabetes in the COVID era

Fast evolution of SARS-CoV-2 driven by extensive RNA deamination by host cells

Dramatic reduction in cervical cancer in the UK following the introduction of HPV vaccination

New CDC report discusses efficacy of mRNA COVID vaccines in immunocompromised

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

Experts reveal improved survival for patients with two out of three types of advanced breast cancer

Study examines benefits of SGLT2 inhibitors in individuals with type 1 diabetes

SARS-CoV-2 infection amplifies immune system–related differences in dialysis, kidney transplant patients

Risk factors for "long-haul" COVID in people with rheumatic diseases identified

Global effort focuses on developing better methods to quantify joint damage in rheumatoid arthritis patients

Health and Social Care Secretary urges people in the UK to get COVID-19 booster jabs

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Latest News